A cluster of radiopharmaceutical companies is growing in Indiana. In our next virtual Frameworx session on May 6th, we will provide an overview of the field, discuss how it’s impacting the life sciences community, and showcase some of the major players in this space.
Tiffany Olson, president, Cardinal Health Nuclear & Precision Health Solutions
Following the keynote, Tiffany will join a panel discussion with Bernard Lambert, president and Chief Operating Officer of Telix Pharmaceuticals (US), Inc., and Dr. Kara Weatherman, clinical associate professor of pharmacy practice at Purdue University College of Pharmacy. The panel will be moderated by BioCrossroads’ senior vice president of external engagement, Brian Stemme.
Please join us on May 6th at 8:30 a.m. ET